Secondary hemophagocytic lymphohistiocytosis, HScore and COVID-19 von Loscocco, Giuseppe G.

Volltext

Role of JAK inhibitors in myeloproliferative neoplasms: current point of view and perspectives von Loscocco, Giuseppe G., Vannucchi, Alessandro M.

Volltext

JAK2V617F variant allele frequency >50% identifies patients with polycythemia vera at high risk for venous thrombosis von Guglielmelli, Paola, Loscocco, Giuseppe G., Mannarelli, Carmela, Rossi, Elena, Mannelli, Francesco, Ramundo, Francesco, Coltro, Giacomo, Betti, Silvia, Maccari, Chiara, Ceglie, Sara, Chiusolo, Patrizia, Paoli, Chiara, Barbui, Tiziano, Tefferi, Ayalew, De Stefano, Valerio, Vannucchi, Alessandro M.

Volltext

One thousand patients with essential thrombocythemia: the Florence-CRIMM experience von Loscocco, Giuseppe G., Gesullo, Francesca, Capecchi, Giulio, Atanasio, Alessandro, Maccari, Chiara, Mannelli, Francesco, Vannucchi, Alessandro M., Guglielmelli, Paola

Volltext

Imatinib is effective in some PDGFRA/B‐negative hypereosinophilic syndromes: A step closer to unveiling underlying mechanisms von Loscocco, Giuseppe G., Helbig, Grzegorz

Volltext

Integration of Molecular Information in Risk Assessment of Patients with Myeloproliferative Neoplasms von Loscocco, Giuseppe G., Coltro, Giacomo, Guglielmelli, Paola, Vannucchi, Alessandro M.

Volltext

Kaposi sarcoma in a patient treated with ruxolitinib von Loscocco, G.G., Vannucchi, M., Paoli, C., Franci, A., Pieri, L., Annunziato, F., Massi, D., Vannucchi, A.M.

Volltext

P985: THE ALLELIC RATIO OF DRIVER AND ASXL1 MUTATIONS IS PROGNOSTICALLY RELEVANT IN PMF von Coltro, G., Rotunno, G., Mannelli, F., Loscocco, G. G., Bartalucci, N., Mannarelli, C., Maccari, C., Guglielmelli, P., Vannucchi, A. M.

Volltext

Mutation‐enhanced international prognostic systems for essential thrombocythaemia and polycythaemia vera von Tefferi, Ayalew, Guglielmelli, Paola, Lasho, Terra L., Coltro, Giacomo, Finke, Christy M., Loscocco, Giuseppe G., Sordi, Benedetta, Szuber, Natasha, Rotunno, Giada, Pacilli, Annalisa, Hanson, Curtis A., Ketterling, Rhett P., Pardanani, Animesh, Gangat, Naseema, Vannucchi, Alessandro M.

Volltext

Bone marrow involvement in small cell lung cancer von Loscocco, Giuseppe G., Piccini, Matteo, Bencini, Sara, Vergoni, Federica

Volltext

Assessment of the efficacy and tolerability of ruxolitinib for the treatment of myelofibrosis patients in a real‐life setting: An Italian MYNERVA Project von Coltro, Giacomo, Sant'Antonio, Emanuela, Palumbo, Giuseppe A., Mannelli, Francesco, De Stefano, Valerio, Ruggeri, Marco, Elli, Elena M., Zanotti, Roberta, Borsani, Oscar, Bertozzi, Irene, Duminuco, Andrea, Betti, Silvia, Carli, Giuseppe, Cavalca, Fabrizio, Tanasi, Ilaria, Rumi, Elisa, Randi, Maria L., Garibaldi, Bruno, Loscocco, Giuseppe G., Guglielmelli, Paola, Vannucchi, Alessandro M.

Volltext

Myeloid sarcoma: more and less than a distinct entity von Loscocco, Giuseppe G., Vannucchi, Alessandro M.

Volltext

Visceral Leishmaniasis von Loscocco, Giuseppe G, Piccini, Matteo

Volltext

Impact of Mutational Profile on the Management of Myeloproliferative Neoplasms: A Short Review of the Emerging Data von Loscocco, Giuseppe G, Guglielmelli, Paola, Vannucchi, Alessandro M

Volltext

The prognostic contribution of CBL, NRAS, KRAS, RUNX1, and TP53 mutations to mutation‐enhanced international prognostic score systems (MIPSS70/plus/plus v2.0) for primary myelofibr... von Loscocco, Giuseppe G., Rotunno, Giada, Mannelli, Francesco, Coltro, Giacomo, Gesullo, Francesca, Pancani, Fabiana, Signori, Leonardo, Maccari, Chiara, Esposito, Maria, Paoli, Chiara, Vannucchi, Alessandro M., Guglielmelli, Paola

Volltext

Concomitant myeloproliferative neoplasm with eosinophilia, B and T cell lymphoblastic lymphoma/leukemia and mast cell proliferation driven by ZMYM2::FGFR1 rearrangement von Loscocco, Giuseppe G., Ascani, Stefano, Mannelli, Francesco, Zanelli, Magda, Rotunno, Giada, Santi, Raffaella, Vannucchi, Alessandro M.

Volltext

Deciphering the individual contribution of absolute neutrophil and monocyte counts to thrombosis risk in polycythemia vera and essential thrombocythemia von Farrukh, Faiqa, Guglielmelli, Paola, Loscocco, Giuseppe G., Pardanani, Animesh, Hanson, Curtis A., De Stefano, Valerio, Barbui, Tiziano, Gangat, Naseema, Vannucchi, Alessandro M., Tefferi, Ayalew

Volltext

A globally applicable "triple A" risk model for essential thrombocythemia based on Age, Absolute neutrophil count, and Absolute lymphocyte count von Tefferi, Ayalew, Loscocco, Giuseppe G, Farrukh, Faiqa, Szuber, Natasha, Mannelli, Francesco, Pardanani, Animesh, Hanson, Curtis A, Ketterling, Rhett P, De Stefano, Valerio, Carobbio, Alessandra, Barbui, Tiziano, Guglielmelli, Paola, Gangat, Naseema, Vannucchi, Alessandro M

Volltext

Clinical and molecular predictors of fibrotic progression in essential thrombocythemia: A multicenter study involving 1607 patients von Loscocco, Giuseppe G., Guglielmelli, Paola, Gangat, Naseema, Rossi, Elena, Mannarelli, Carmela, Betti, Silvia, Maccari, Chiara, Ramundo, Francesco, Jadoon, Yamna, Gesullo, Francesca, Ceglie, Sara, Paoli, Chiara, Pardanani, Animesh, De Stefano, Valerio, Tefferi, Ayalew, Vannucchi, Alessandro M.

Volltext

SF3B1 mutations in primary and secondary myelofibrosis: Clinical, molecular and prognostic correlates von Loscocco, Giuseppe G., Guglielmelli, Paola, Mannelli, Francesco, Mora, Barbara, Mannarelli, Carmela, Rotunno, Giada, Pancani, Fabiana, Maccari, Chiara, Bartalucci, Niccolò, Romagnoli, Simone, Coltro, Giacomo, Passamonti, Francesco, Vannucchi, Alessandro M.

Volltext